Matteo S. Carlino - Dissemin

Language
Login

Papers authored by Matteo S. Carlino

This paper is made freely available by the publisher.

2020 Abhishikta Dey

ORCID

, Nicholas Manolios

ORCID

, Georgina V. Long, Matteo S. Carlino

ORCID

, Richard Kefford, Leslie Schrieber

Musculoskeletal immune‐related adverse events with use of checkpoint inhibitors in malignancy

Download from onlinelibrary.wiley.com

This paper was not found in any repository, but could be made available legally by the author.

Tw W. Wang, Jl L. Smith, M. Carlino

ORCID

, B. Burmeister, Mb B. Pinkham, Gb B. Fogarty, D. Christie, V. Estall, M. Shackleton, T. L. T. Phuong, E. J. Paton, R. Wolfe, V. Steel, N. C. Williams

Evaluating the Safety and Tolerability of the Combination of Dabrafenib, Trametinib and Palliative Radiotherapy in Patients with Metastatic BRAF V600E/K Mutation-positive Cutaneous Melanoma

Upload

This paper is made freely available by the publisher.

Kazi J. Nahar

ORCID

, Robert V. Rawson, Tasnia Ahmed, Stephen Tattersall, Neomal Sandanayake, Christopher J. Kiely, Serigne Lo

ORCID

, Matteo Carlino

ORCID

, Umaimainthan Palendira, Georgina V. Long, Richard A. Scolyer

ORCID

, Alexander M. Menzies

Clinicopathological characteristics and management of colitis with anti-PD1 immunotherapy alone or in combination with ipilimumab

Download from doi.org

This paper is made freely available by the publisher.

Eric Whitman, Pablo Fernandez-Penas, Matteo Carlino

ORCID

, Katy Tsai, Tom Van Hagen, Victoria Atkinson, Andrew Mant, Marcus Butler, Monaster Shaheen, Gregory Daniels, Elizabeth Buchbinder, Sajeve Thomas, John Hyngstrom, Mecker Moller, Igor Puzanov and 25 other authors

799 Durable responses and immune activation with intratumoral electroporation of pIL-12 plus pembrolizumab in actively progressing anti-PD-1 refractory advanced melanoma: KEYNOTE 695 interim data

Download from doi.org

This paper is made freely available by the publisher.

Ryan J. Sullivan, Jeffrey Weber, Sapna Patel

ORCID

, Reinhard Dummer, Matteo S. Carlino

ORCID

, Daniel Sw W. Tan, Celeste Lebbé, Salvatore Siena

ORCID

ORCID

, Michael D. Pickard, Lance Wollenberg, Victor Sandor, Paolo A. Ascierto

ORCID

A Phase Ib/II Study of the BRAF Inhibitor Encorafenib Plus the MEK Inhibitor Binimetinib in Patients with BRAFV600E/K-mutant Solid Tumors

Download from aacrjournals.org

This paper is made freely available by the publisher.

Shahneen Sandhu

ORCID

, Susana Puig, Piotr Rutkowski, Dirk Schadendorf

ORCID

, Alfonsus J. M. van den Eertwegh, Alexander C. J. van Akkooi, Stefan Suciu

ORCID

, Caroline Robert

ORCID

, Alexander Mm M. Eggermont, Christian U. Blank, Mario Mandala, Georgina V. Long

ORCID

, Victoria G. Atkinson, James Larkin

ORCID

, Stéphane Dalle and 16 other authors

Longer Follow-Up Confirms Recurrence-Free Survival Benefit of Adjuvant Pembrolizumab in High-Risk Stage III Melanoma: Updated Results From the EORTC 1325-MG/KEYNOTE-054 Trial

Download from doi.org

This paper is made freely available by the publisher.

Oliver Klein, Damien Kee

ORCID

, Ben Markman, Michael Michael

ORCID

, Craig Underhill

ORCID

, Matteo S. Carlino

ORCID

, Louise Jackett, Caroline Lum

ORCID

ORCID

, Andreas Behren

ORCID

ORCID

, Adnan Nagrial, Jodie Palmer

ORCID

, Jonathan Cebon

ORCID

Immunotherapy of Ipilimumab and Nivolumab in Patients with Advanced Neuroendocrine Tumors: A Subgroup Analysis of the CA209-538 Clinical Trial for Rare Cancers

Download from aacrjournals.org

This paper is made freely available by the publisher.

Russell J. Diefenbach

ORCID

, Jenny H. Lee, Alexander M. Menzies, Matteo S. Carlino

ORCID

, Georgina V. Long

ORCID

, Robyn Pm M. Saw, Julie R. Howle, Andrew J. Spillane, Richard A. Scolyer

ORCID

, Richard F. Kefford, Helen Rizos

Design and Testing of a Custom Melanoma Next Generation Sequencing Panel for Analysis of Circulating Tumor DNA

Download from doi.org

This paper is made freely available by the publisher.

Matteo S. Carlino

ORCID

, John A. Thompson, Haiyan Wu, Alexander M. Menzies, Victoria G. Atkinson, Jonathan S. Cebon

ORCID

, Michael B. Jameson

ORCID

, Bernard M. Fitzharris, Catriona M. McNeil

ORCID

, Andrew Graham Hill, Wen-Jen Hwu, F. Stephen Hodi, Antoni Ribas, Alexander D. Guminski, Michael B. Atkins and 4 other authors

Long-Term Follow-Up of Standard-Dose Pembrolizumab Plus Reduced-Dose Ipilimumab in Patients With Advanced Melanoma: KEYNOTE-029 Part 1B

Download from aacrjournals.org

This paper is made freely available by the publisher.

Dmitrii Shek, Scott A. Read, Matteo S. Carlino

ORCID

, Adnan Nagrial, Bo Gao, Golo Ahlenstiel

Pre-treatment predictors of immune-mediated hepatitis in non-small cell lung cancer patients treated with immune-checkpoint inhibitors: A retrospective study.

Download from doi.org

This paper is made freely available by the publisher.

Shahneen Kaur Sandhu

ORCID

, Alexander M. Eggermont, Susana Puig, Alexander Christopher Jonathan Van Akkooi, Stefan Suciu, Caroline Robert, Christian U. Blank, Mario Mandalà, Georgina V. Long, Victoria Atkinson, Stéphane Dalle, Andrew Mark Haydon, Andrey Meshcheryakov, Paolo Antonio Ascierto, Muhammad Khattak and 6 other authors

Pembrolizumab versus placebo after complete resection of high-risk stage III melanoma: New recurrence-free survival results from the EORTC 1325-MG/Keynote 054 double-blinded phase III trial at three-year median follow-up.

Download from doi.org

This paper is made freely available by the publisher.

John J. Park, Russell J. Diefenbach, Natalie Byrne, Richard Kefford, Georgina V. Long, Richard A. Scolyer, Elin Gray, Matteo S. Carlino

ORCID

, Helen Rizos

Circulating tumor DNA (ctDNA) in patients (pts) with metastatic uveal melanoma (UM) treated with protein kinase C inhibitor (PKCi).

Download from doi.org

This paper is made freely available by the publisher.

Victoria Atkinson, Kathleen Batty, Georgina V. Long, Matteo S. Carlino

ORCID

, Geoffrey David Peters, Prachi Bhave, Maggie A. Moore, Wen Xu, Lauren Julia Brown, Megan Lyle, Melissa Arneil, Alexander M. Menzies

Activity and safety of third-line BRAF-targeted therapy (TT) following first-line TT and second-line immunotherapy (IT) in advanced melanoma.

Download from doi.org

This paper is made freely available by the publisher.

Jenny Hj Lee, Matteo S. Carlino

ORCID

, Alexander M. Menzies, Justin Iver Odegaard, Martina Lefterova, Richard A. Scolyer, Georgina V. Long, Helen Rizos

Circulating tumor DNA (ctDNA) using Guardant360 to predict response in BRAF V600 WT metastatic melanoma (MM) patients (pts) receiving immune checkpoint inhibitors (ICI).

Download from doi.org

This paper is made freely available by the publisher.

Georgina V. Long, Jacob Schachter, Ana Arance, Jean-Jacques Grob, Laurent Mortier, Adil Daud, Matteo S. Carlino

ORCID

, James M. G. Larkin, Paul Lorigan, Antoni Ribas, Bart Neyns, Catriona M. McNeil, Christian U. Blank, Michal Lotem, Teresa M. Petrella and 5 other authors

Long-term survival from pembrolizumab (pembro) completion and pembro retreatment: Phase III KEYNOTE-006 in advanced melanoma.

Download from doi.org

This paper is made freely available by the publisher.

Nicolas van Baren, Peter A. Johansson, Kelly Brooks, Felicity Newell, Jane M. Palmer

ORCID

, Lambros T. Koufariotis, James S. Wilmott, Vaishnavi Nathan

ORCID

, Aaron B. Beasley

ORCID

, Antonia L. Pritchard, Madeleine Howlie, Rebecca Dawson, Natasa Broit, Helen Rizos

ORCID

, Chris W. Schmidt

ORCID

and 20 other authors

Whole genome landscapes of uveal melanoma show an ultraviolet radiation signature in iris tumours

Download from www.nature.com

This paper is made freely available by the publisher.

Dmitrii Shek

ORCID

, Scott A. Read

ORCID

, Liia Akhuba, Liang Qiao, Bo Gao, Adnan Nagrial, Matteo S. Carlino

ORCID

, Golo Ahlenstiel

ORCID

Non-coding RNA and immune-checkpoint inhibitors: friends or foes?

Download from doi.org

This paper is made freely available by the publisher.

Jenny H. Lee

ORCID

, Alexander M. Menzies, Matteo S. Carlino

ORCID

, Ashleigh C. McEvoy

ORCID

, Shahneen Sandhu

ORCID

, Alison M. Weppler, Russell J. Diefenbach

ORCID

, Stephen Q. Wong, Sarah-Jane Dawson, Zeyad Al-Ogaili, Richard F. Kefford, Thien Tra, Michael J. Millward, Elin S. Gray

ORCID

, Richard A. Scolyer

ORCID

and 2 other authors

Longitudinal monitoring of ctDNA in patients with melanoma and brain metastases treated with immune checkpoint inhibitors

Download from aacrjournals.org

This paper is made freely available by the publisher.

Jenny H. Lee, Elena Shklovskaya, Su Yin Lim, Matteo S. Carlino

ORCID

, Alexander M. Menzies, Ashleigh Stewart, Bernadette Pedersen, Dario Strbenac, Malama Irvine, Robyn P. M. Saw

ORCID

, Sara Alavi, John F. Thompson

ORCID

, James S. Wilmott

ORCID

, Jean Yh H. Yang

ORCID

, Richard A. Scolyer and 3 other authors

Transcriptional downregulation of MHC class I and melanoma de- differentiation in resistance to PD-1 inhibition

Download from www.nature.com

This paper is made freely available by the publisher.

Michele Maio, Matteo Carlino

ORCID

, Anthony Joshua, Elaine McWhirter, Antoni Ribas, Paolo Ascierto, Wilson Miller, Marcus Butler, Michele Del Vecchio, Pier Ferrucci, Eduard Gasal, Razi Ghori, Robert Zielinski, Scott Diede, Elizabeth Croydon and 1 other authors

P863 KEYNOTE-022 parts 4 and 5: pembrolizumab plus trametinib for patients with solid tumors or BRAF wild-type melanoma

Download from doi.org

Missing publications? Search for publications with a matching author name.